AR222985A1 - Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales - Google Patents

Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales

Info

Publication number
AR222985A1
AR222985A1 AR274986A AR27498678A AR222985A1 AR 222985 A1 AR222985 A1 AR 222985A1 AR 274986 A AR274986 A AR 274986A AR 27498678 A AR27498678 A AR 27498678A AR 222985 A1 AR222985 A1 AR 222985A1
Authority
AR
Argentina
Prior art keywords
pirido
hydrazone
tetrahydro
pyrimidine
oxo
Prior art date
Application number
AR274986A
Other languages
English (en)
Spanish (es)
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Application granted granted Critical
Publication of AR222985A1 publication Critical patent/AR222985A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR274986A 1977-12-29 1978-12-28 Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales AR222985A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1794A HU178496B (en) 1977-12-29 1977-12-29 Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity

Publications (1)

Publication Number Publication Date
AR222985A1 true AR222985A1 (es) 1981-07-15

Family

ID=10994683

Family Applications (3)

Application Number Title Priority Date Filing Date
AR274986A AR222985A1 (es) 1977-12-29 1978-12-28 Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales
AR280147A AR228949A1 (es) 1977-12-29 1980-03-03 Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
AR280146A AR227882A1 (es) 1977-12-29 1982-03-03 Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR280147A AR228949A1 (es) 1977-12-29 1980-03-03 Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
AR280146A AR227882A1 (es) 1977-12-29 1982-03-03 Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales

Country Status (29)

Country Link
US (2) US4234586A (ko)
JP (1) JPS5495598A (ko)
AR (3) AR222985A1 (ko)
AT (1) AT375936B (ko)
AU (1) AU520428B2 (ko)
BE (1) BE873194A (ko)
CA (1) CA1130284A (ko)
CH (1) CH642078A5 (ko)
CS (1) CS244654B2 (ko)
DD (1) DD139854A5 (ko)
DE (1) DE2854115A1 (ko)
DK (1) DK157022C (ko)
ES (7) ES476442A1 (ko)
FI (1) FI66614C (ko)
FR (1) FR2413389A1 (ko)
GB (1) GB2011898B (ko)
GR (1) GR68357B (ko)
HU (1) HU178496B (ko)
IL (1) IL56078A (ko)
IT (1) IT1203210B (ko)
LU (1) LU80601A1 (ko)
NL (1) NL7812547A (ko)
NO (1) NO151287C (ko)
PL (5) PL119641B1 (ko)
PT (1) PT68935A (ko)
SE (1) SE438675B (ko)
SU (2) SU999972A3 (ko)
YU (3) YU42093B (ko)
ZA (1) ZA787385B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
US4482557A (en) * 1979-05-11 1984-11-13 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 3-Substituted-2-oxo-tetrahydro-pyrrol[1,2-a]pyrimidines having digitalis-like activity
HU176942B (hu) * 1979-05-11 1981-06-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija 2,3- i 3,4-dvuzamehhjonnykh tetragidro-pirrolo!1,2-a!-pirimidinov
HU178452B (en) * 1979-05-11 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 9-substituted amino-4-oxo-6,7-dihydro-4h-pyrido/1,2-a/pyrimidine derivatives
HU179443B (en) * 1979-05-11 1982-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing substituted geminal dihalogeno-derivatives of pyrido-square bracket-1,2-a-square closed-pyrimidines,pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines and pyrimido-square bracket-1,2,-a-square bracket closed-asepines
HU178453B (en) * 1979-05-11 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-hydrazino-4-oxo-6,7,8,9-tetrahydro-4h-p-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
AT381093B (de) * 1980-06-24 1986-08-25 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren
HU183173B (en) * 1980-06-24 1984-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 6-hydrazono-pyrido-aracket-2,1-b-bracket closed-quinazolin-11-ones
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
US4395549A (en) * 1981-10-02 1983-07-26 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones
US5344933A (en) * 1991-09-11 1994-09-06 Fuji Photo Film Co., Ltd. Pyrrole ring-or condensed pyrrole ring-containing azomethine dye
EP1790649A1 (en) * 2005-11-21 2007-05-30 Sanofi-Aventis Substituted bicyclic pyrimidone derivatives
EP2138498A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted tricyclic derivatives against neurodegenerative diseases
EP2138495A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
EP2138488A1 (en) 2008-06-26 2009-12-30 sanofi-aventis 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
EP2138492A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidin-4-one derivatives
EP2138493A1 (en) 2008-06-26 2009-12-30 Sanofi-Aventis Substituted pyrimidone derivatives
EP2138494A1 (en) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituted alkyl pyrimidin-4-one derivatives
EP2138485A1 (en) 2008-06-26 2009-12-30 sanofi-aventis Substituted N-Oxide pyrazine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786056A (en) * 1954-05-03 1957-03-19 Merck & Co Inc Acylamido-hydroxy pteridines and preparation thereof
US2894031A (en) * 1958-09-16 1959-07-07 Grace W R & Co Process for cyclohexanone hydrazone hydrate
US3140315A (en) * 1959-02-18 1964-07-07 Bayer Ag Alkyl-substituted hydrazines and hydrazones and process for preparation thereof
FR1255365A (fr) * 1959-12-22 1961-03-10 Cfmc Nouveaux colorants basiques, leur procédé de préparation et leurs applications
US3141043A (en) * 1961-03-24 1964-07-14 Purdue Research Foundation Cyclopentadienylimines, process for their production and condensation products thereof
CH441366A (de) * 1961-06-09 1967-08-15 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinverbindungen
US3417082A (en) * 1965-08-16 1968-12-17 Polaroid Corp Novel chemical compounds and syntheses
AT286990B (de) * 1966-11-02 1971-01-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
HU168014B (ko) * 1973-03-30 1976-02-28
US4024132A (en) * 1973-09-07 1977-05-17 Ciba-Geigy Corporation Azomethine pigments
HU174693B (hu) * 1976-02-12 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija kondensirovannykh proizvodnykh pirimidina
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity

Also Published As

Publication number Publication date
YU41538B (en) 1987-08-31
GB2011898A (en) 1979-07-18
AR228949A1 (es) 1983-05-13
US4461769A (en) 1984-07-24
GR68357B (ko) 1981-12-23
CH642078A5 (de) 1984-03-30
IT7869933A0 (it) 1978-12-22
FI66614C (fi) 1984-11-12
ES481747A1 (es) 1980-07-01
YU279582A (en) 1983-10-31
FR2413389B1 (ko) 1982-03-26
YU42062B (en) 1988-04-30
YU42093B (en) 1988-04-30
ZA787385B (en) 1980-02-27
NL7812547A (nl) 1979-07-03
DE2854115A1 (de) 1979-07-12
ES481748A1 (es) 1980-07-01
FI66614B (fi) 1984-07-31
NO151287B (no) 1984-12-03
AT375936B (de) 1984-09-25
DD139854A5 (de) 1980-01-23
SU999972A3 (ru) 1983-02-23
FR2413389A1 (fr) 1979-07-27
BE873194A (fr) 1979-04-17
NO151287C (no) 1985-03-13
DK157022B (da) 1989-10-30
SU978730A3 (ru) 1982-11-30
PL122965B1 (en) 1982-09-30
PL119641B1 (en) 1982-01-30
AR227882A1 (es) 1982-12-30
DE2854115C2 (ko) 1988-07-28
PL119520B1 (en) 1982-01-30
JPS5495598A (en) 1979-07-28
ATA873678A (de) 1984-02-15
PL212212A1 (ko) 1980-02-25
CA1130284A (en) 1982-08-24
PL119501B1 (en) 1982-01-30
DK157022C (da) 1990-04-02
AU520428B2 (en) 1982-01-28
ES481745A1 (es) 1980-07-01
PL125321B1 (en) 1983-04-30
AU4262778A (en) 1979-07-05
ES481746A1 (es) 1980-07-01
PT68935A (en) 1979-01-01
ES476442A1 (es) 1979-11-16
IL56078A (en) 1982-11-30
US4234586A (en) 1980-11-18
CS244654B2 (en) 1986-08-14
ES481744A1 (es) 1980-06-16
IL56078A0 (en) 1979-01-31
DK585578A (da) 1979-06-30
GB2011898B (en) 1982-04-28
NO784393L (no) 1979-07-02
FI784013A (fi) 1979-06-30
YU296478A (en) 1983-10-31
HU178496B (en) 1982-05-28
SE7813226L (sv) 1979-06-30
CS909178A2 (en) 1985-08-15
LU80601A1 (de) 1979-03-22
SE438675B (sv) 1985-04-29
IT1203210B (it) 1989-02-15
ES481749A1 (es) 1980-07-01
JPH0146514B2 (ko) 1989-10-09
YU279682A (en) 1983-10-31

Similar Documents

Publication Publication Date Title
AR219565A1 (es) Procedimiento para la preparacion de compuestos de 4-(di-n-propil)amino-1,3,4,5-tetrahidrobenc(c1d)indol y sus sales
AR220704A1 (es) Procedimiento para la preparacion de derivados de indanil y tetrahidronaftil octatrieno
MX5950E (es) Procedimiento para la preparacion de derivados de la pirrolidin-2-ona
AR222985A1 (es) Procedimiento para la preparacion de nuevos derivados de 9-hidrazono-4-oxo-6,7,8,9-tetrahidro-4h-pirido(1,2-a)pirimidina y sus sales
MX5527E (es) Procedimiento para la preparacion de derivados de carboestirilo
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
AR220158A1 (es) Procedimiento para la preparacion de nuevos 1,9-dihidroxioctahidrofenantrenos 3,6-sustituidos y 1-hidroxioctahidrofenantren-9-onas 3,6-sustituidas
AR219560A1 (es) Procedimiento para la preparacion de derivados de 5,5-dimetil-hidantoina
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
AR225410A1 (es) Procedimiento para la preparacion de nuevos nucleosidos
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR215162A1 (es) Procedimiento mejorado para la preparacion de acido d,1-5-metiltetrahidrofolico y sus sales
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
MX5479E (es) Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR227087A1 (es) Procedimiento para obtener compuestos de s-triazol(4,3-b)-piridazinas y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR217688A1 (es) Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol
AR218296A1 (es) Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina
MX5534E (es) Procedimiento para la preparacion de derivados de nicotinamida
AR223015A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-(4-(1,4(5)-benzodioxaciclohexil(heptil)-2-carbonil)-piperazin-1-il)quinazolina y sus sales de adicion de acidos farmaceuticamente aceptables
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
MX5191E (es) Procedimiento para la preparacion de derivados de n'-fenil-n-metilurea
AR219310A1 (es) Procedimiento para la preparacion de derivados de 4,5-diciclo-2-(tio-sustituido)-imidazoles y sus correspondientes sulfonas